-
Pfizer puts Emergen-C into its consumer med cabinetPfizer ($PFE) is snapping up the company that makes Emergen-C, those ubiquitous vitamin C packets that sell for some $10 a box. The world's biggest drugmaker will add California-based Alacer to its co2012/3/1
-
In drugs vs. stents debate, another point for medsMore ammo for drugmakers in the ongoing battle of stents vs. pills. A U.S. study found drug therapy works just as well for stable patients with narrowed heart arteries, without the risks and costs of2012/2/29
-
SFDA Commissioner Yin Li meets Director of Health Bureau of Macao SAR and signs cooperation agreementOn February 23, 2012, Yin Li, Commissioner of the State Food and Drug Administration (SFDA), met with Dr. Lei Chin Ion, Director of the Health Bureau of Government of Macao Special Administrative Regi2012/2/29
-
Lilly adds to Irish ops with $440M plantIrish officials may be worried about drug exports bottoming out with the patent cliff--and with good reason. But Eli Lilly ($LLY) has given the pharma industry there a new boost: The U.S.-based compan2012/2/28
-
GSK chief: Officials delay new meds to save moneyGlaxoSmithKline ($GSK)chief Andrew Witty (pictured) is raising a ruckus in Europe, accusing governments of not only cutting prices and drug budgets, but holding off on adopting newmeds to save money.2012/2/28
-
Field narrows in contest for Pfizer's nutrition unitThe contest for Pfizer's nutrition unit is heating up. Mead Johnson, the baby-formula business spun off by Bristol-Myers Squibb ($BMY) in 2009, has teamed up with the French food giant Danone on a bid2012/2/27
-
GSK hits back at XenoPort in RLS drug disputeXenoPort knew it would get GlaxoSmithKline's ($GSK) attention with a termination notice. But the sort of attention it wanted? Probably not the sort it got.GSKhas sued the smaller company, its partner2012/2/27
-
CDC delay could temper adult uptake of Pfizer's Prevnar shotPfizer ($PFE)has pinned big hopes on Prevnar 13, the latest version of its vaccine against pneumococcus bacteria. It's already commonly used in infants and children to prevent pneumonia and meningitis2012/2/24
-
FDA adds 14 Chinese suppliers to heparin hot listFour years later, the FDA is still uncovering perps in the tainted heparin scandal. The agency said it found 14 more Chinese companies that supplied contaminated raw heparin back in 2008, when the blo2012/2/24
-
Yin Li appointed as Party Secretary and Commissioner of SFDAIn February 2012, the Central Committee of the Communist Party of China (CCCPC) and the State Council appointed Yin Li as Party Secretary and Commissioner of the State Food and Drug Administration (SF2012/2/23